| Financial Year |
March 31 2023 |
| Monetary Funds |
5,340,803,852.15 |
| Held-for-trading Financial Assets |
20,858,464.00 |
| Notes Receivable |
75,491,518.57 |
| Accounts Receivable |
3,547,228,459.62 |
| Advances to Suppliers |
214,043,163.40 |
| Other Receivables |
230,826,116.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,374,727,771.13 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
65,020,823.44 |
| Other Current Assets |
247,626,097.10 |
| Total Current Assets |
15,719,187,748.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
13,505,065.13 |
| Long-term Equity Investment |
218,504,628.66 |
| Investment Properties |
407,646,764.04 |
| Fixed Assetes |
4,718,236,000.10 |
| Under-construction Projects |
241,803,777.52 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
790,533,701.14 |
| R&D expenses |
-- |
| Goodwill |
406,554,744.00 |
| Long-Term Deferred and Prepaid Expenses |
31,522,671.65 |
| Deferred Income Tax Assets |
141,598,940.19 |
| Other Non-Current Assets |
57,840,404.37 |
| Sub-Total of Non-Current Assets |
7,292,000,876.17 |
| Total Assets |
23,011,188,624.32 |
| Short-Term Loans |
319,889,420.77 |
| Trading Financial liabilities |
-- |
| Notes Payable |
788,084,246.67 |
| Accounts Payable |
3,910,851,014.77 |
| Accounts Received In Advance |
7,775,883.97 |
| Employee Compensation Payable |
607,765,755.92 |
| Taxes Payable |
498,436,915.08 |
| Interest Payable |
-- |
| Dividend Payable |
2,291,956.19 |
| Other payables |
1,058,973,414.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
133,259,395.43 |
| Other Current Liabilities |
247,976,831.51 |
| Sub-Total of Current Liabilities |
8,474,407,150.76 |
| Long-term Loans |
373,310,857.65 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
112,352,872.10 |
| Other Non-Current Liabilities |
16,109,157.15 |
| Sub-Total of Non-Current Liabilities |
754,843,314.18 |
| Total Liabilities |
9,229,250,464.94 |
| Paid-In Capital(Or Share Stock) |
2,017,600,000.00 |
| Capital Surplus |
4,800,309,693.04 |
| Surplus Reserve |
322,977,011.06 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,966,381,621.84 |
| Minority Stockholder's Interest |
654,781,115.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,127,157,044.23 |
| Owner's Equity（Stockholder's Equity） |
13,781,938,159.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
23,011,188,624.32 |
